Search research articles
Contact Us
Filters
Showing results (81-90 of 87) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 87 results.
Cancer Discovery
|
September 23, 2021
<i>MYC</i> Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma
Ravikanth Maddipati, Robert J Norgard, Timour Baslan, et al.
JCO Precision Oncology
|
August 11, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Diana Merino Vega, Katherine K Nishimura, Névine Zariffa, et al.
Nature
|
March 8, 2019
Hepatocytes direct the formation of a pro-metastatic niche in the liver
Jae W Lee, Meredith L Stone, Paige M Porrett, et al.
Gut
|
December 20, 2023
Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer
Roni Ben-Ami, Qiao-Li Wang, Jinming Zhang, et al.
Nature Medicine
|
March 22, 2022
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Vivek Narayan, Julie S Barber-Rotenberg, In-Young Jung, et al.
Nature Communications
|
July 9, 2024
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma
Jacob E Till, Lee McDaniel, Changgee Chang, et al.
Cell
|
June 15, 2026
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM
Nelson F Freeburg, Daniel Chafamo, Gayathri Konanur Gopikrishna, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 87) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 87 results.
Cancer Discovery
|
September 23, 2021
<i>MYC</i> Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma
Ravikanth Maddipati, Robert J Norgard, Timour Baslan, et al.
JCO Precision Oncology
|
August 11, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Diana Merino Vega, Katherine K Nishimura, Névine Zariffa, et al.
Nature
|
March 8, 2019
Hepatocytes direct the formation of a pro-metastatic niche in the liver
Jae W Lee, Meredith L Stone, Paige M Porrett, et al.
Gut
|
December 20, 2023
Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer
Roni Ben-Ami, Qiao-Li Wang, Jinming Zhang, et al.
Nature Medicine
|
March 22, 2022
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Vivek Narayan, Julie S Barber-Rotenberg, In-Young Jung, et al.
Nature Communications
|
July 9, 2024
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma
Jacob E Till, Lee McDaniel, Changgee Chang, et al.
Cell
|
June 15, 2026
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM
Nelson F Freeburg, Daniel Chafamo, Gayathri Konanur Gopikrishna, et al.
Page
of 9